Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-16 Purchase |
2020-10-20 8:07 pm |
Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
235,000 | $15 | $3,525,000 | 2,503,903 (Indirect) |
View |
| 2020-09-18 Purchase |
2020-09-22 11:07 am |
Metacrine Inc. | MTCR | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
230,000 | $13 | $2,990,000 | 158,734 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2020-12-17 8:03 pm |
N/A N/A |
908 Devices Inc. | MASS | ARCH Venture Fund VII L.P. ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC BYBEE CLINTON NELSEN ROBERT 10% Owner |
0 | $0 | 5,425,045 (Direct) |
View |
| 2020-11-20 Other |
2020-11-24 8:59 pm |
N/A N/A |
Quanterix Corp | QTRX | ARCH VENTURE FUND VI LP ARCH Venture Fund VIII Overage L.P. ARCH VENTURE PARTNERS VI LP ARCH VENTURE PARTNERS VI LLC ARCH Venture Partners VIII LLC BYBEE CLINTON NELSEN ROBERT 10% Owner |
833,211 | $0 | 2,049,870 (Indirect) |
View |
| 2020-11-12 Other |
2020-11-16 6:15 pm |
N/A N/A |
Karuna Therapeutics Inc. | KRTX | NELSEN ROBERT Director 10% Owner |
76,757 | $0 | 1,759,949 (Indirect) |
View |
| 2020-10-16 Conversion |
2020-10-20 8:07 pm |
N/A N/A |
Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
30,658,565 | $0 | 2,503,903 (Indirect) |
View |
Ownership |
2020-10-13 9:23 pm |
N/A N/A |
Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
0 | $0 | 3,620,109 (Indirect) |
View |
| 2020-05-21 Option Award(A) |
2020-10-13 7:09 pm |
2021-05-21 2030-05-20 |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
24,885 | $0 | 24,885 (Direct) |
View |
| 2020-09-18 Conversion |
2020-09-22 11:07 am |
N/A N/A |
Metacrine Inc. | MTCR | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
2,710,503 | $0 | 158,734 (Indirect) |
View |
Ownership |
2020-09-15 5:07 pm |
N/A N/A |
Metacrine Inc. | MTCR | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner |
0 | $0 | 2,710,503 (Indirect) |
View |
| 2020-06-18 Option Award |
2020-06-22 5:28 pm |
N/A 2030-06-17 |
Unity Biotechnology Inc. | UBX | NELSEN ROBERT Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 4:43 pm |
N/A 2030-06-04 |
Karuna Therapeutics Inc. | KRTX | NELSEN ROBERT Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 6:02 pm |
N/A 2030-06-02 |
Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director 10% Owner |
18,436 | $0 | 18,436 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-26 5:00 pm |
2021-05-21 2030-05-21 |
Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner |
28,888 | $0 | 28,888 (Direct) |
View |